Bundibugyo,<\/a>\u00a0qui s\u00e9vit actuellement en Afrique de l\u2019Ouest sans vaccin ni traitement efficace. Elle se dit capable de commercialiser un rem\u00e8de en 24 mois, soit \u00abpour la prochaine \u00e9pid\u00e9mie\u00bb, mais demande pour cela un investissement public de 15 millions d\u2019euros.<\/p>\n\u00abEn mati\u00e8re de maladie infectieuse \u00e9mergente, on s\u2019aper\u00e7oit que quand on n\u2019est pas pr\u00e9par\u00e9 ou que l\u2019on n\u2019a pas d\u2019outil permettant de r\u00e9pondre aux mutations des virus, on n\u2019a plus d\u2019arsenal th\u00e9rapeutique, observe S\u00e9bastien Iva, PDG de Fabentech, aupr\u00e8s du Figaro. Or la base de notre technologie est d\u2019avoir un spectre tr\u00e8s large\u2026<\/p>\n
\n Cet article est r\u00e9serv\u00e9 aux abonn\u00e9s. Il vous reste 67% \u00e0 d\u00e9couvrir.\n <\/p>\n
![\"Le]()
<\/p>\n
Vente Flash<\/p>\n
-70% sur votre abonnement. Sans engagement.<\/p>\n
\n D\u00e9j\u00e0 abonn\u00e9\u00a0?
\n Connectez-vous
\n <\/a>\n <\/p>\n","protected":false},"excerpt":{"rendered":"Convaincue de pouvoir mettre au point un traitement en 24 mois, la biotech lyonnaise sollicite un soutien financier…\n","protected":false},"author":2,"featured_media":1026757,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[10],"tags":[99231,1011,27,72,71,24504,5336],"class_list":["post-1026756","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sante","tag-ebola","tag-fr","tag-france","tag-health","tag-sante","tag-variant","tag-virus"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/116818921827530935","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/1026756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=1026756"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/1026756\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/1026757"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=1026756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=1026756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=1026756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}